Spinal USA: IIQ 2025 Update

A long under-performing healthcare company has had its debt extended -again. The discount applied, though, suggests something is seriously wrong even if the debt is nominally performing. P.S. We suggest two companies readers might want to keep an eye on in the IIIQ 2025.